SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: jopawa who wrote (2293)10/23/1998 9:44:00 PM
From: Keith Fauci  Respond to of 4676
 
thanks



To: jopawa who wrote (2293)10/24/1998 8:49:00 PM
From: Scott H. Davis  Read Replies (1) | Respond to of 4676
 
I think Onyx is one of them. Also from a release Sept 3 (AGPH has moved substantially since then)
''Several second-tier companies are particularly attractive at current prices because they are oversold and have less risk
than some of the smaller companies,'' McCamant said. ''Isis (NASDAQ:ISIP - news), for example, can double from
current prices and still be undervalued. AxyS (NASDAQ:AXPH - news) and ImClone Systems (NASDAQ:IMCL -
news) are two others in that group. A few other stocks that are appear particularly undervalued right now are Agouron
((NASDAQ:AGPH - news) and ICOS (NASDAQ:ICOS - news). As leaders provide momentum, lower-priced
companies that can move quickly include XOMA (NASDAQ:XOMA - news), Shaman (NASDAQ:SHMN - news) and
Immunogen (NASDAQ:IMGN - news).''

Hope this helps (I don't get his newsletter) Scott